Thomas S. Murray

23.1k total citations · 6 hit papers
80 papers, 18.8k citations indexed

About

Thomas S. Murray is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Thomas S. Murray has authored 80 papers receiving a total of 18.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 19 papers in Pulmonary and Respiratory Medicine and 15 papers in Infectious Diseases. Recurrent topics in Thomas S. Murray's work include Antibiotic Resistance in Bacteria (14 papers), Cystic Fibrosis Research Advances (12 papers) and Bacterial biofilms and quorum sensing (10 papers). Thomas S. Murray is often cited by papers focused on Antibiotic Resistance in Bacteria (14 papers), Cystic Fibrosis Research Advances (12 papers) and Bacterial biofilms and quorum sensing (10 papers). Thomas S. Murray collaborates with scholars based in United States, Saudi Arabia and Italy. Thomas S. Murray's co-authors include Phyllis A. Wingo, Sarah Landis, Alicia Samuels, Ahmedin Jemal, Elizabeth Ward, Robert T. Greenlee, M. J. Thun, Ateeq Ur Rehman Ghafoor, Ram C. Tiwari and Eric J. Feuer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Thomas S. Murray

75 papers receiving 18.2k citations

Hit Papers

Cancer Statistics, 2005 1998 2026 2007 2016 2005 2000 2003 1999 1998 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cancer Statistics, 2005
    2005 4.7k citations Thomas S. Murray et al. CA A Cancer Journal for Clinicians profile →
  2. Cancer statistics, 2000
    2000 3.3k citations Thomas S. Murray, Phyllis A. Wingo et al. CA A Cancer Journal for Clinicians profile →
  3. Cancer Statistics, 2003
    2003 2.8k citations Thomas S. Murray et al. CA A Cancer Journal for Clinicians profile →
  4. Cancer statistics, 1999
    1999 2.7k citations Sarah Landis, Thomas S. Murray et al. CA A Cancer Journal for Clinicians profile →
  5. Cancer statistics, 1998
    1998 2.0k citations Sarah Landis, Thomas S. Murray et al. CA A Cancer Journal for Clinicians profile →
  6. Microbiota regulates immune defense against respiratory tract influenza A virus infection
    2011 1.1k citations David R. Peaper, Thomas S. Murray et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas S. Murray United States 27 6.6k 6.1k 5.3k 3.2k 2.2k 80 18.8k
Thomas S. Murray United States 11 6.9k 1.0× 5.8k 0.9× 5.2k 1.0× 3.0k 0.9× 2.8k 1.2× 14 17.6k
Giuseppe Tonini Italy 62 8.8k 1.3× 4.8k 0.8× 4.1k 0.8× 2.9k 0.9× 2.3k 1.0× 530 17.6k
Keitaro Matsuo Japan 71 6.4k 1.0× 5.5k 0.9× 4.3k 0.8× 4.0k 1.2× 2.5k 1.1× 736 21.4k
Hans Gelderblom Netherlands 76 9.6k 1.4× 5.8k 0.9× 9.6k 1.8× 2.8k 0.9× 2.3k 1.0× 743 25.3k
Deepa Naishadham United States 21 8.0k 1.2× 8.1k 1.3× 5.3k 1.0× 3.3k 1.0× 4.6k 2.1× 26 22.7k
Marise Souto Rebelo Brazil 5 8.2k 1.2× 7.2k 1.2× 5.4k 1.0× 4.0k 1.2× 4.7k 2.1× 6 22.7k
Sultan Eser Türkiye 15 8.6k 1.3× 7.3k 1.2× 5.5k 1.0× 4.0k 1.3× 4.7k 2.1× 43 23.4k
Hai‐Rim Shin South Korea 37 7.9k 1.2× 5.6k 0.9× 4.6k 0.9× 4.7k 1.5× 3.5k 1.5× 77 21.7k
David E. Neal United Kingdom 77 5.7k 0.9× 8.4k 1.4× 7.6k 1.4× 4.3k 1.4× 3.0k 1.4× 559 22.3k
Rajesh Dikshit India 30 9.6k 1.4× 7.8k 1.3× 6.0k 1.1× 4.5k 1.4× 5.1k 2.3× 103 26.6k

Countries citing papers authored by Thomas S. Murray

Since Specialization
Citations

This map shows the geographic impact of Thomas S. Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas S. Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas S. Murray more than expected).

Fields of papers citing papers by Thomas S. Murray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas S. Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas S. Murray. The network helps show where Thomas S. Murray may publish in the future.

Co-authorship network of co-authors of Thomas S. Murray

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas S. Murray. A scholar is included among the top collaborators of Thomas S. Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas S. Murray. Thomas S. Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murray, Thomas S., Erica S. Shenoy, Scott C. Roberts, et al.. (2025). Applying principles to practice: cleaning and disinfection of extended reality equipment used in healthcare settings. Infection Control and Hospital Epidemiology. 46(8). 855–857.
2.
Feinn, Richard, et al.. (2024). Particle size distribution of viable nebulized bacteriophage for the treatment of multi-drug resistant Pseudomonas aeruginosa. Respiratory Medicine and Research. 86. 101133–101133. 2 indexed citations
3.
Zhang, Xinwei, Suge Zhang, Feiran Zhang, et al.. (2024). Asian and Asian American early educators’ racial discrimination experiences and student well-being during COVID-19: A moderated mediation model. Early Childhood Research Quarterly. 69. S60–S70. 2 indexed citations
4.
Shabanova, Veronika, et al.. (2024). The diagnostic utility of obtaining two blood cultures for the diagnosis of early onset sepsis in neonates. Journal of Perinatology. 44(5). 745–747. 1 indexed citations
5.
Pana, Zoi Dorothea, Mortada El‐Shabrawi, Thomas S. Murray, et al.. (2023). Fighting the hidden pandemic of antimicrobial resistance in paediatrics: recommendations from the International Pediatric Association. BMJ Paediatrics Open. 7(1). e002084–e002084. 5 indexed citations
6.
Malik, Amyn A., John Eric Humphries, Thomas S. Murray, et al.. (2022). Relationship between the use of nonpharmaceutical interventions and COVID-19 vaccination among U.S. child care providers: A prospective cohort study. Vaccine. 40(31). 4098–4104. 1 indexed citations
7.
Murray, Thomas S., Gail Stanley, & Jonathan L. Koff. (2022). Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis. Clinics in Chest Medicine. 43(4). 667–676. 8 indexed citations
8.
Malik, Amyn A., John Eric Humphries, Thomas S. Murray, et al.. (2021). COVID-19 Vaccine Uptake Among US Child Care Providers. PEDIATRICS. 148(5). 8 indexed citations
9.
Roberts, Scott C., David R. Peaper, L. Scott Sussman, et al.. (2021). Mass severe acute respiratory coronavirus 2 (SARS-CoV-2) testing of asymptomatic healthcare personnel. Infection Control and Hospital Epidemiology. 42(5). 625–626. 6 indexed citations
10.
Pietro, Caterina Di, Hasan Halit Öz, Thomas S. Murray, & Emanuela M. Bruscia. (2020). Targeting the Heme Oxygenase 1/Carbon Monoxide Pathway to Resolve Lung Hyper-Inflammation and Restore a Regulated Immune Response in Cystic Fibrosis. Frontiers in Pharmacology. 11. 1059–1059. 30 indexed citations
11.
Murray, Thomas S., et al.. (2019). The Ethics of Fecal Microbiota Transplant as a Tool for Antimicrobial Stewardship Programs. The Journal of Law Medicine & Ethics. 47(4). 541–554. 2 indexed citations
12.
Schramm, Craig M., et al.. (2018). Repeated hot water and steam disinfection of Pari LC Plus® nebulizers alter nebulizer output. Journal of Cystic Fibrosis. 18(2). 233–235. 5 indexed citations
13.
Talwalkar, Jaideep S. & Thomas S. Murray. (2016). The Approach to Pseudomonas aeruginosa in Cystic Fibrosis. Clinics in Chest Medicine. 37(1). 69–81. 68 indexed citations
14.
Murray, Thomas S., et al.. (2015). Baby bottle steam sterilizers for disinfecting home nebulizers inoculated with non-tuberculous mycobacteria. Journal of Hospital Infection. 92(3). 222–225. 7 indexed citations
15.
Somily, Ali M., et al.. (2014). ESBL-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care hospital in Saudi Arabia. The Journal of Infection in Developing Countries. 8(9). 1129–1136. 28 indexed citations
16.
Farrel, Patricia, et al.. (2012). Baby bottle steam sterilizers disinfect home nebulizers inoculated with bacterial respiratory pathogens. Journal of Cystic Fibrosis. 12(5). 512–516. 9 indexed citations
17.
Lan, Lefu, Thomas S. Murray, Barbara I. Kazmierczak, & Chuan He. (2009). Pseudomonas aeruginosaOspR is an oxidative stress sensing regulator that affects pigment production, antibiotic resistance and dissemination during infection. Molecular Microbiology. 75(1). 76–91. 63 indexed citations
18.
Murray, Thomas S. & Michael Cappello. (2008). The Molecular Diagnosis of Parasitic Diseases. The Pediatric Infectious Disease Journal. 27(2). 163–164. 8 indexed citations
19.
Kazmierczak, Barbara I., et al.. (2006). Analysis of FimX, a phosphodiesterase that governs twitching motility in Pseudomonas aeruginosa. Molecular Microbiology. 60(4). 1026–1043. 159 indexed citations
20.
Landis, Sarah, et al.. (1999). Cancer statistics, 1999. CA A Cancer Journal for Clinicians. 49(1). 8–31. 2673 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas S. Murray Breakdown of academic impact, for papers by Giuseppe Tonini Breakdown of academic impact, for papers by Keitaro Matsuo Breakdown of academic impact, for papers by Hans Gelderblom Breakdown of academic impact, for papers by Deepa Naishadham Breakdown of academic impact, for papers by Marise Souto Rebelo Breakdown of academic impact, for papers by Sultan Eser Breakdown of academic impact, for papers by Hai‐Rim Shin Breakdown of academic impact, for papers by David E. Neal Breakdown of academic impact, for papers by Rajesh Dikshit
Rankless by CCL
2026